Corresponding to these data, the CD44 cell surface receptor is expressed by many immortalized human and rodent glioma cell lines [30,31,33], but its levels may vary dramatically, even between single cell-derived colonies of the same line, e.g., up to 20-fold for U-251 MG glioblastoma [34]. This evidence concerns the gene CD44 and central nervous system cancer.